Introduction
Cardiovascular disease (CVD) is one of the major causes of mortality in the Western world, and dyslipidemia is an important risk factor in the development of CVD. Low levels of HDL-cholesterol (C), high levels of VLDL-and LDL-C and high levels of triglycerides (TG) are independent risk factors for CVD 120, 121 . The ratio of (V)LDL-C to HDL-C is to a great extent affected by the cholesteryl ester transfer protein (CETP). , at least two novel CETP inhibitors (i.e. and anacetrapib) are currently in different phases of clinical trials 123, 124 .
Despite the well described effects of CETP on plasma cholesterol metabolism, the role of CETP in TG metabolism has been studied less well. The torcetrapib and JTT-705 trials showed that inhibition of CETP in humans affects both the cholesterol and TG distribution over lipoproteins 125, 126 . It was also reported that JTT-705 reduces plasma TG in patients with combined hyperlipidemia 127 , which may reveal a beneficial effect of CETP inhibition on plasma TG levels.
Furthermore, in rabbits, enrichment of HDL with TG by CETP increases the catabolism of HDL by hepatic lipase (HL)
128
. Thus, CETP has the potential to affect TG metabolism, which may have effects on tissue-specific lipid accumulation.
VLDL-derived TG are lipolyzed in peripheral tissues by the enzyme lipoprotein lipase (LPL), whereas HDL-derived TG are presumably lipolyzed by HL and thus shunted to the liver. Therefore, we hypothesized that the CETP mediated net transfer of TG from (V)LDL to HDL modulates the tissue-specific uptake of plasma TG and, as a consequence, affects the development of high fat diet-induced obesity. 
Materials and Methods

Animals
Plasma parameters
Plasma was obtained after overnight fasting (unless indicated otherwise) via tail vein bleeding in chilled paraoxon-coated capillary tubes to prevent ex vivo lipolysis, and assayed for TG and total cholesterol using commercially available kits 1488872 and 236691 from Roche Molecular Biochemicals (Indianapolis, IN, USA), respectively. Plasma CETP mass was analyzed using the CETP ELISA kit from ALPCO Diagnostics (Salem, NH, USA). FFA were measured using NEFA C kit from Wako Diagnostics (Instruchemie, Delfzijl, the Netherlands).
HL activity in plasma was determined by measuring plasma triacylglycerol hydrolase activity as described earlier 130 .
Lipoprotein profiling
To determine the lipid distribution over plasma lipoproteins, lipoproteins were separated using fast protein liquid chromatography (FPLC). Plasma was pooled per group, and 50 μL of each pool was injected onto a Superose 6 PC 3.2/30 column (Äkta System, Amersham Pharmacia Biotech, Piscataway, NJ, USA) and eluted at a constant flow rate of 50 μL/min in PBS, 1 mM EDTA, pH 7.4. Fractions of 50 μL were collected and assayed for cholesterol and TG as described above.
Postprandial response
Mice were fasted overnight with food withdrawn at 6:00 p.m. the day before the experiment. Mice received an intragastric olive oil load (Carbonell, Cordoba, Spain) of 200 μL. Prior to the bolus and 1, 2, 3, 4, 6 and 10 h after the bolus, blood samples (30 μL) were drawn via tail bleeding for TG determination as described above. The circulating levels were corrected for the levels of TG prior to the bolus and the area under the curve (AUC) was calculated over the period of 0-10 h using GraphPad software.
Hepatic VLDL-TG and VLDL-apoB production
Mice were fasted for 4 h with food withdrawn at 5:00 a.m. prior to the start of the experiment. During the experiment, mice were sedated with 6.25 mg/ kg acepromazine (Alfasan), 6.25 mg/kg midazolam (Roche), and 0.3125 mg/ kg fentanyl (Janssen-Cilag). At t=0 min blood was taken via tail bleeding and mice were i.v. injected with 100 μL PBS containing 100 μCi Trans 35 S label to measure de novo total apoB synthesis. After 30 min, the animals received 500 mg of tyloxapol (Triton WR-1339, Sigma-Aldrich) per kg body weight as a 10% (w/w) solution in sterile saline, to prevent systemic lipolysis of newly secreted hepatic VLDL-TG 131 . Additional blood samples were taken at t=15, 30, 60, and 90 min after tyloxapol injection and used for determination of plasma TG concentration. At 120 min, the animals were sacrificed and blood was collected by orbital puncture for isolation of VLDL by density gradient ultracentrifugation.
35
S-labeled total apoB content was measured in the VLDL fraction after precipitation with isopropanol 132, 133, 134 . 
In vivo clearance of VLDL-like emulsion particles
Statistical analysis
Differences between groups were determined with the unpaired T-test for normally distributed data (GraphPad Prism 5 software, La Jolla, CA). A P-value of less than 0.05 was considered statistically significant. Data are presented as means ± SEM.
Results
Plasma lipids, lipoprotein profiles and hepatic lipase activity
To investigate the role of CETP in TG metabolism, male and female E3L and E3L.CETP mice were fasted overnight and plasma lipid levels were determined (Table 1) . Expression of CETP had no effect on total plasma lipid levels. Since we did not detect a difference between males and females, we decided to use males only for all subsequent experiments. Plasma lipoprotein profiles were determined on pooled plasma. Expression of CETP resulted in a shift of cholesterol from HDL to VLDL (Fig. 1A) , as seen previously 116, 119 . Furthermore, a small amount of TG was detected in the HDL fraction upon expression of CETP (insert Fig. 1B ). HL activity was did not differ between E3L and E3L.
CETP mice (3.9 ± 1.5 vs 3.2 ± 1.3 μmol FFA/h/mL, respectively). This indicates that there is exchange of TG from the VLDL to the HDL fraction by CETP, which may be indicative of changes in TG metabolism. 12 h fasted mice were bled. Plasma was collected, pooled per group (n=12), and subjected to FPLC to separate lipoproteins Distribution of cholesterol (A) and triglycerides (B) over lipoproteins was determined.
Postprandial TG clearance
To examine whether CETP-mediated transfer of TG from VLDL to HDL influences plasma TG metabolism, we determined postprandial TG response.
After an overnight fast, mice received an intragastric gavage of olive oil.
Plasma TG concentrations were measured over a 10 h-period and the AUC was calculated. Expression of CETP in E3L mice did not affect the postprandial TG changes in plasma (Fig. 2) .
Figure 3. VLDL-TG and VLDL-apoB production.
4 h fasted mice were consecutively injected with Trans 35 S label and tyloxapol and blood samples were drawn up to 90 min (n=4-6 per group). TG concentrations were determined in plasma and plotted as the increase in plasma TG (A). After 120 min, the total VLDL fraction was isolated by ultracentrifugation and the rate of newly synthesized VLDL-apoB (B) and the ratio of TG over apoB (C) was calculated. Overnight fasted mice received an intragastric olive oil gavage and blood samples were drawn up to 10 h (n=6-9 per group). Plasma TG concentrations were determined and area under the curve (AUC 0-10 ) was calculated.
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VLDL-TG and VLDL-apoB production
To further examine the effect of CETP on TG metabolism we determined VLDL production. After 4 h of fasting, mice were injected with Trans 35 S and tyloxapol and the accumulation of endogenous VLDL-TG in plasma was measured over time. As is evident from Fig. 3A , the VLDL-TG production rate, as determined from the slope of the curve, was unchanged upon expression of CETP. Furthermore, the rate of VLDL-apoB production (Fig. 3B) as well as the ratio of TG over apoB (Fig. 3C) , reflecting the amount of TG per VLDL particle, did not differ between E3L and E3L.CETP mice.
VLDL-like emulsion-TG clearance
Clearance of TG from circulation is also a major determinant of TG metabolism and therefore we examined the effect of CETP on TG clearance from VLDL-like emulsions, which have previously been shown to mimic the metabolic behaviour of TG-rich lipoproteins 135, 137 . After 4 h fasting, mice were injected with a bolus of was not affected by the expression of CETP (Fig. 4) and brown adipose tissue (BAT) was not altered due to the expression of CETP (Fig. 5B) . The serum half-life and organ specific uptake of [ 14 C]FA were also not changed upon expression of CETP (data not shown).
High fat diet-induced obesity
We and others have previously shown that modulation of tissue-specific TGderived FA delivery can have a major impact on the development of high fat diet-induced obesity (reviewed in 138 ). To exclude the possibility that CETP expression results in a minor change in tissue-specific TG-derived FA uptake that over a prolonged period would affect the development of obesity, E3L
and E3L.CETP mice were fed a high fat diet (60% energy% in the form of fat)
for 12 weeks, and body weight was measured over time. The high fat diet did not affect plasma CETP levels in E3L.CETP mice (3.8 ± 0.4 μg/mL on chow and 3.6 ± 0.3 μg/mL on high fat diet). Furthermore the high fat diet resulted in a similar decrease in plasma TG in both E3L and E3L.CETP mice (1.04 ± 0.11 and 0.92 ± 0.14 mmol/L, respectively). CETP did not affect the high fat dietinduced body weight gain at any time point during the 12 weeks (Fig. 6 ). 
Discussion
Novel drugs that inhibit CETP activity as therapy to increase HDL-C levels are in various stages of development 123, 124 . The rationale for development of these drugs is based on HDL-lowering effect of CETP due to the redistribution of . In this study, after 4 hour fasting, plasma cholesterol were somewhat higher in the E3L.CETP mice. In the current study, we find no changes in plasma total cholesterol and TG after overnight fasting.
We do find a small increase in TG in the HDL fraction upon expression of CETP in E3L mice. Despite this relative increase in HDL-TG, CETP did not affect the postprandial TG response, hepatic VLDL-TG production, clearance of TG from VLDL-like emulsion particles and the development of high fat diet-induced obesity. These findings suggest that CETP-mediated transfer of TG from (V)LDL to HDL does not reflect a substantial effect on overall plasma TG metabolism in E3L mice.
There is some controversy on the effects of CETP on TG metabolism in various mouse models. Studies in mice, expressing simian CETP, show that on an atherogenic diet expression of CETP results in increased production metabolism and high fat diet-induced obesity in E3L mice. This implicates that, at least under relatively normolipidemic conditions, pharmacological CETP inhibition is unlikely to disturb TG metabolism.
